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Objective: This study was undertaken to assess the frequency and outcome of cardiovascular surgery in children
with Marfan or Loeys-Dietz syndrome.
Methods:A retrospective review from 2 regional Marfan subspecialty clinics was performed. Between 1997 and
2007, 204 children with Marfan syndrome and 17 children with Loeys-Dietz syndrome were followed serially. Of
these patients, 35 were identified who had undergone cardiovascular surgery at 18 years of age or less. Demo-
graphic, echocardiographic, and surgical data were collected.
Results: Surgery was performed at a median of 3 years (0–15 years) after diagnosis and a mean age of 11.5 6.2
years. Aortic root replacement was the initial surgery in 30 patients, and mitral valve surgery was the initial sur-
gery in 8 patients, with 3 patients undergoing both. Aortic root replacement was performed using a composite root
replacement in 9 patients and valve-sparing techniques in 21 patients (remodeling in 8 patients and reimplantation
in 13 patients). Eight patients underwent reoperation at a mean of 4.7 3.0 years after aortic surgery: 3 for aortic
insufficiency, 2 for dissection, 2 for valve thrombosis, and 1 for a distal aneurysm. Adverse outcomes included
reoperation in 8 patients, aneurysm in 1 patient, and death due to dissection or stroke in 3 patients. Variables as-
sociated with an adverse outcome included preoperative aortic insufficiency, valve replacement, and absence of
angiotensin-converting enzyme inhibitor therapy.
Conclusion: Patients with Marfan or Loeys-Dietz syndrome requiring surgery during childhood have a favorable
long-term outcome. Those undergoing valve-sparing root replacement or mitral valve repair have a low risk for
reoperation. Postoperative angiotensin-converting enzyme inhibitor therapy confers clinical benefit.
CONGENITAL HEART DISEASEMarfan syndrome (MFS) is an autosomal dominant disorder
marked by the triad of musculoskeletal, aortic, and ocular
pathology.1 The primary cause of morbidity and mortality
associated with MFS is aortic dissection.2 In 1968, Bentall
and de Bono3 described the technique of replacing the as-
cending aorta and aortic valve in a patient with MFS. Nu-
merous surgical advances followed, including remodeling4
and reimplantation5 techniques aimed at sparing the pa-
tient’s own aortic valve, thereby rendering long-term antico-
agulation unnecessary. The majority of patients with MFS
will not require surgical intervention until their adult years.6
Loeys-Dietz syndrome (LDS) is a recently recognized ge-
netic disorder marked by craniofacial and musculoskeletal
abnormalities and aggressive aortic pathology.7 As in
MFS, the disorder is associated with premature morbidity
and mortality secondary to aortic dissection.7 Indications
for surgical replacement of the dilated aorta have been pub-
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earlier surgical intervention is indicated.8
Although cardiovascular surgery in the adult with MFS or
related syndromes has beenwell described, there are little data
on the need for cardiovascular surgery in children with these
aortopathies.8-11 In addition, little is known about the long-
term outcome of cardiovascular surgery in these patients.
We sought to assess the frequency and long-term outcome
of cardiovascular surgery in children with MFS or LDS.
MATERIALS AND METHODS
Patient Population
After institutional review board approval, a retrospective data review
was undertaken at the Intermountain West Marfan Cardiology Institute,
comprised of 2 pediatric cardiology centers: Primary Children’s Medical
Center, Salt Lake City, Utah, and The Children’s Hospital, Denver, Colo-
rado. The diagnosis of MFS was made in accordance with the Ghent crite-
ria.12 LDS was diagnosed in those patients with aortic dilation, typical
craniofacial features, and a documented TGFBRI or TGFBRII disease-caus-
ing mutation.7 The clinical database was reviewed, and patients who under-
went surgical intervention in childhood (age< 18 years) were identified.
Demographic, echocardiographic, and surgical data were collected on these
patients, including age at diagnosis, clinical features, preoperative medical
therapy, age at surgery, indication for surgical intervention, type of surgery,
presence and type of major postoperative complications (arrhythmia, pro-
longed ventilation, need for in-hospital reoperation, stroke, death), duration
of follow-up, need for reoperation, aortic dissection, and death.
Echocardiography
All patients underwent semiannual echocardiography and echocardiog-
raphy immediately preoperatively and postoperatively. Data obtainedardiovascular Surgery c Volume 137, Number 6 1327




LDS ¼ Loeys-Dietz syndrome
MFS ¼ Marfan syndrome
from the echocardiogram at last preoperative visit, first postoperative assess-
ment, and last clinical visit were used for data analysis. Systolic aortic root
dimension, obtained from the parasternal long-axis view, was expressed as
an absolute value and an indexed score for body surface area (Z-score).13
Left ventricular function was expressed as an ejection fraction obtained
from volumetric analysis in the apical 4- and 2-chamber views. Mitral insuf-
ficiency was assessed in a semiqualitative manner and judged to be trivial,
mild, moderate, or severe using regurgitant jet area to left atrial area ratio
and mitral insufficiency jet width.
Surgical Techniques
In general, standard hypothermic cardiopulmonary bypass (28C) and
blood potassium cardioplegic arrest were used for all cases. Replacement
of the aortic valve and root was performed using a modified Bentall tech-
nique.14 Valve-sparing root replacement was performed using a remodeling
technique with annular fixation15 or a reimplantation technique.16,17 Mitral
valve surgery consisted of standard repair or replacement techniques.18
Data Analysis
Data are summarized as frequencies, means  standard deviations, or
medians with ranges where appropriate. Patients who underwent aortic sur-
gery were divided into 2 groups on the basis of the presence or absence of an
adverse clinical outcome, defined as the need for reoperation, new aortic dis-
section, or death. Patient characteristics for the 2 groups were compared us-
ing Fisher’s exact test or chi-square analysis for categoric variables and t
tests andKruskal–Wallis analysis of variance for continuous variables. Mul-
tiple logistic regression analysis was performed on those risk factors found
to be significant by univariate analysis.
Patient survival and adverse event-free survival were calculated and pre-
sented in Kaplan–Meier format.19
RESULTS
Patient Population
Of the 204 children with MFS and 17 children with LDS
followed at 2 institutions comprising the Intermountain
West Marfan Cardiology clinic, 24 (11% of entire MFS pe-
diatric cohort) and 11 (65% of entire LDS cohort) required
surgical intervention in childhood. Patient follow-up and cri-
teria for surgery were uniform across the institutions. Initial
surgical intervention was performed at a mean age of 11.5
6.2 years (range, 9 months to 18 years). Sixty-nine percent of
the patients were male. Forty percent of the patients had
a family history of MFS or LDS. Ten patients (28%) under-
went repeat surgical intervention at a mean interval of 4.1
3.0 years.
Of the 35 children, 30 had an aortic procedure performed
at the time of initial surgical intervention. The demographics
of these 30 patients are displayed in Tables 1 and 2.
Eight patients underwent mitral valve surgery at the time
of initial intervention. All carried the diagnosis of MFS. All
6 patients with neonatal MFS required mitral valve surgery,
3 of whom underwent concomitant aortic surgery.1328 The Journal of Thoracic and Cardiovascular SuEchocardiography
Patients were followed clinically with echocardiography
for a mean of 8.9  5.6 years after initial surgical interven-
tion. Echocardiographic variables are shown in Table 3.
Surgical Intervention
A total of 35 patients underwent first-time surgical inter-
vention. The primary indication for surgery was aortic aneu-
rysm in 30 patients and mitral valve insufficiency in 5
patients.
Aortic surgery. Initial aortic intervention was performed at
a mean age of 14.2  4.3 years. Median time to aortic sur-
gery after diagnosis was 3 years (range 0–15 years). Indica-
tions for surgical intervention were rapid aortic growth (1
cm per year) in 1 patient, aortic dissection in 4 patients with
LDS, aortic dilation with insufficiency in 5 patients, and at-
tainment of established surgical criteria for aortic root re-
placement in 15 patients with MFS and in 5 patients with
LDS. Criteria included an absolute aortic sinus diameter of
45 to 50 mm or greater for patients with MFS and an aortic
sinus diameter indexed to body surface area of 3.5 or greater
(Z-score) for patients with LDS. Aortic root replacement
was performed in 3 patients at the time of mitral valve sur-
gery because of dissection in 1 patient and aortic aneurysm
in 2 patients. In 9 patients, the initial operation consisted of
replacement of the aortic valve and ascending aorta using
a mechanical prosthesis in 8 patients and a bioprosthesis in
1 patient. One of these patients had a mitral prosthesis placed
concomitantly. Aortic valve replacement was performed in
all patients with moderate or greater preoperative insuffi-
ciency or in the setting of aortic dissection. In 8 patients, a re-
modeling technique with annular fixation was used. One of
these 8 patients with remodeling underwent simultaneous
mitral valve repair. Thirteen patients underwent a primary
valve-sparing root procedure using a reimplantation tech-
nique, with 1 of these patients undergoing simultaneous
atrial septal defect closure and another undergoing mitral
valve repair.
Eight patients in this cohort underwent reintervention at
a mean time from initial surgery of 4.7  3.0 years. Of the
9 patients who underwent aortic valve replacement, 4 re-
quired reintervention for the following reasons: valve throm-
bosis (2), an aneurysm at the distal end of the ascending graft
(1), and dissection (1) in a patient with LDS. Reoperation
was necessary in 4 of the 21 patients who had a valve-spar-
ing procedure. Of the 8 patients who underwent valve-spar-
ing root replacement using the remodeling technique, 2
required valve replacement 4 and 6 years after the initial
procedure because of the development of significant aortic
insufficiency. A third patient with LDS underwent reopera-
tion for dissection distal to the ascending graft. One of the 13
patients who underwent valve-sparing root replacement us-
ing the reimplantation technique developed significant aorticrgery c June 2009
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DTABLE 1. Patient characteristics at diagnosis and initial aortic surgery
Diagnosis Age at diagnosis (y) Age at surgery (y)
Aorta at surgery: diameter
(mm) (indexed to BSA)
Medication preoperatively;
postoperatively Surgery
LDS 0 3 28 (8) ACE; ACEI Reimplantation
nMFS 0 2 38 (13) BB; ACEI Reimplantation
nMFS 2 6 40 (16) BB; ACEI Remodeling
LDS 2 2 51 (26) None; ACEI Reimplantation
MFS 2 9 50 (8) BB; BB AVR
MFS 6 17 50 (7) BB; BB Reimplantation
MFS 15 18 49 (11) BB; ACEI Reimplantation
LDS 3 3 32 (9) BB; BB Remodeling
MFS 18 18 57 (9) None; ACEI Reimplantation
LDS 0 1 26 (9) ACEI; ACEI Reimplantation
nMFS 0 1 35 (NA) BB; BB AVR
LDS 9 9 55 (25) None AVR
MFS 7 15 54 (7) BB; ACEI Reimplantation
MFS 4 14 50 (7) BB; ACEI AVR
LDS 18 18 60 (9) None; None AVR
MFS 3 8 48 (13) BB; BB Remodeling
MFS 14 14 54 (9) BB; ACEI Remodeling
MFS 6 14 53 (11) BB; None Remodeling
MFS 17 18 68 (12) BB; BB Reimplantation
MFS 14 15 NA None; None Reimplantation
MFS 10 17 53 (6) None; ACEI Reimplantation
MFS NA 18 45 (5) BB; BB Reimplantation
MFS 19 18 67 (9) None; ACEI Remodeling
MFS 10 17 52 (8) None; BB AVR
LDS 0 14 43 (7) BB; ACEI AVR
LDS 6 16 52 (7) BB; BB AVR
LDS 3 18 59 (8) None; BB AVR
LDS 10 12 52 (15) None; BB Remodeling
LDS 12 17 39 (4) None; ACEI Reimplantation
MFS NA 13 50 (10) BB; BB Remodeling
BSA, Body surface area; LDS, Loeys-Dietz syndrome; nMFS, neonatal Marfan syndrome; MFS, Marfan syndrome; NA, not available; ACEI, angiotensin-converting enzyme
inhibitor; BB, beta-blocker; AVR, aortic valve replacement.insufficiency necessitating valve replacement 4 years after
the valve-sparing operation. Surgical variables related to ini-
tial aortic root procedures are as shown in Table 4. Mean fol-
low-up time of patients surviving initial aortic surgery was
4.6  3.2 years (0.5–13 years). There was 1 early death in
the valve replacement cohort and no deaths in the valve-
sparing cohort.
Mitral valve surgery. A total of 8 patients underwent mi-
tral valve surgery as their first surgical intervention at a me-
dian age of 4 years (range 0–12 years). Median time to mitral
valve surgery after diagnosis was 1.5 years (range, 0–11
years). Indications for mitral valve surgery included flail
valve with ruptured chordae in 3 patients with neonatal
MFS and severe mitral insufficiency with symptoms of con-
gestive heart failure in 5 patients, including 1 patient with
left ventricular enlargement and associated ventricular dys-
rhythmias. Mitral valve repair was the anticipated surgical
procedure in all patients, but valve replacement was required
in 2 patients: extensive mitral annular and valve calcificationThe Journal of Thoracic and Cin 1 patient and placement of a mechanical aortic prosthesis
for severe aortic insufficiency not amenable to repair in 1 pa-
tient. One patient required reintervention at 5 months post-
operatively because of severe mitral regurgitation through
a hole in the valve leaflet. The valve was amenable to repair
with mild regurgitation at last follow-up. Another patient un-
derwent an aortic valve-sparing root replacement for attain-
ment of absolute aortic root dimension of 50 mm 30 months
after mitral valve surgery. Mean follow-up time was 4.8 
3.0 years. There were no deaths in this group.
Entire surgical cohort. The duration of follow-up for the
entire cohort was 8.9 5.6 years. Freedom from reoperation
was 94% at 1 year, 89% at 3 years, 73% at 5 years, and
66% at 8 years. Patient survival was 97% at 1 month,
94% at 1 year, 90% at 3 years, and 84% at 5 and 8 years (Fig-
ure 1). There were 3 cardiac-related deaths on follow-up, all in
patients with a diagnosis of LDS. Two were in-hospital
deaths. One in-hospital death occurred in an undiagnosed
9-year-old child who presented with loss of consciousnessardiovascular Surgery c Volume 137, Number 6 1329
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Dcaused by acute dissection of the ascending aorta with exten-
sion into the carotid arteries. Despite successful repair of
the dissection, neurologic status remained poor and therapy
was withdrawn. The other in-hospital death occurred in a
19-year-old girl who had undergone a Bentall procedure for
aortic dissection 7 months earlier; endocarditis with thrombo-
embolism subsequently developed, and the patient died de-
spite successful surgical repair. The third death occurred in
a 14-year-old child with LDS 3 years after aortic surgery us-
ing the valve-sparing technique. The patient had acute dissec-
tion distal to the ascending aortic graft andwas dead on arrival






Gender, male 78% 67% .678
Preoperative height, cm 180 174 .754
Preoperative weight, kg 33 41 .581
Age at diagnosis, y 8.3 6.5 .676
Diagnosis: MFS/LDS 13/ 5 6/ 6 .216
Age at first surgery, y 12.5 11.5 .496
Positive family history 18 12 .880
Preoperative medical
therapy
Duration, y 3.8 4.7 .474
BB vs ACEIb 82% vs 18% 100% vs 0 .485
Postoperative medical
therapy
BB vs ACEIb 25% vs 75% 100% vs 0 .006
MFS,Marfan syndrome; LDS, Loeys-Dietz syndrome; BB, beta-blocker; ACEI, angio-
tensin-converting enzyme inhibitor. aAdverse outcome is defined as death, dissection,
or need for reoperation. bPercent of patients with or without an adverse outcome who
were receiving beta-blocker therapy versus percent of patients with specified outcome
receiving an ACEI.









Absolute size, mm 36.9 37.1 .934
Z-score 5.9 10.1 .066
Aortic root
dimension at surgery
Absolute size, mm 47.8 49.8 .626
Z-score 9.9 11.9 .397
Aortic insufficiency
at surgery,
moderate or more 1 (5%) 8 (67%) <.001
Preoperative dissection 0 2 (17%) .142
LV dysfunction,
ejection fraction<40%
Postoperative 2 (11%) 3 (25%) .364
At last follow-up 2 (12%) 5 (42%) .092
LV, Left ventricular.1330 The Journal of Thoracic and Cardiovascular Suto the hospital. There were no in-hospital deaths in patients
undergoing prophylactic root replacement.
Statistical Analysis
Predictors of adverse outcomes after aortic surgery were
sought using univariate and multivariate analyses. Adverse
outcomes included the need for reoperation in 9 patients
and cardiac-related death in 3 patients with LDS.
Univariate analysis. The results from univariate analysis
are shown in Tables 2 to 4. Predictors of adverse outcome
included the presence of preoperative aortic insufficiency,
non–valve-sparing surgical intervention, and lack of angio-
tensin-converting enzyme inhibitor use postoperatively. Age
at surgical intervention and preoperative aortic diameter
(absolute or indexed) did not predict adverse outcome.
Similarly, underlying diagnosis and presence of preopera-
tive aortic dissection were not related to outcome in this
small patient group.
Multiple logistic regression analysis. Because of the
small sample size, a full multivariate analysis with stepwise







Year of surgery, 2002 14 (74%) 6 (50%) .179
Type of surgery, .006
Mechanical valve 2 (11%) 7 (58%)
VSRR 16 (89%) 5 (42%)
VSRR .027
Remodeling 4 (25%) 4 (80%)
Reimplantation 12 (75%) 1 (20%)
Graft size, mm 25.6 23.6 .881
CPB time, min 185 161 .315
Crossclamp time, min 163 148 .558
VSSR, Valve-sparing root replacement; CPB, cardiopulmonary bypass.
FIGURE 1. Freedom from reoperation and actual survival.rgery c June 2009
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Dlogistic regression was not performed, but those variables
that were found to be significantly associated with adverse
outcome by univariate analysis were analyzed by logistic re-
gression. This included the type of aortic surgery, preopera-
tive aortic insufficiency, and the type of postoperative
medical therapy. Absence of medical therapy with an angio-
tensin-converting enzyme inhibitor remained a risk factor for
adverse outcome when controlling for the other 2 variables
(P ¼ .04). The presence of moderate or greater preoperative
aortic insufficiency also remained an important variable (P¼
.05). The type of aortic surgery did not (Table 5).
DISCUSSION
Because of earlier diagnosis, more patients with MFS or
LDS are undergoing surgical intervention during childhood.
We have demonstrated that surgical outcomes in this group
of patients are good with low morbidity and mortality rates.
Aortic repair using placement of a mechanical valve was
a univariate risk factor associated with adverse long-term
outcomes. However, when multivariate analysis was per-
formed, the presence of preoperative aortic insufficiency
appeared to confound this finding. This is not surprising
because the indication for placement of a mechanical bio-
prosthesis in most patients was aortic insufficiency not ame-
nable to repair. Notably, 44% of patients in this subset
underwent reintervention for valve thrombosis (2 patients),
distal dissection (1 patient), and aneurysm (1 patient).
Thus, although durability with respect to aortic insufficiency
was achieved, the need for relatively early reintervention
was not circumvented. The potential complications of bleed-
ing or thrombosis related to anticoagulation for prosthetic
valves cannot be overemphasized. Maintenance of appropri-
ate anticoagulation is particularly problematic in younger
patients when compliance is an issue.
Outcomes were favorable in those patients with MFS un-
dergoing a valve-sparing operation, specifically, the early
and intermediate results of valve-sparing root replacement
using the reimplantation technique in this cohort of patients
with connective tissue abnormalities were excellent with
only 1 patient requiring reintervention for aortic insuffi-
ciency 4 years after initial repair. Although advocates of
the remodeling technique emphasize the value of recreating
the aortic sinuses to minimize stress on the valve leaflets and
preserve functioning, the results in this group of pediatric pa-
tients do not lend weight to the remodeling technique over that
of reimplantation. In fact, patients with aortic aneurysm due to
MFS or Marfan-like syndromes may fare better with the reim-
plantation technique because fixation of the annulus prevents
regurgitation caused by annular dilatation. This has been sug-
gested by others who cite a greater risk of late annular dilatation
and aortic insufficiency when the remodeling technique is
used.20 Statistical analysis beyond the univariate comparison
(P ¼ .03) was not performed because of the small number of
patients undergoing each valve-sparing technique. Nonetheless,The Journal of Thoracic and Cour observation that supports valve-sparing surgery using the
reimplantation technique rather than remodeling is in accord
with the results of other small studies of valve-sparing surgery
in children or young adults with MFS.10,21
Noteworthy in this population is that the need for reinter-
vention in both the valve replacement and valve-sparing
groups cannot be solely attributed to the surgical technique
but rather in part to the nature of the aortic disease. The out-
comes highlight the extent of the aortic pathology and risk of
dissection distal to the ascending graft, especially in patients
with LDS. Since 2000, all of our patients with MFS or LDS
undergo assessment of the entire aorta by magnetic reso-
nance angiography or computed tomographic angiography
before and after aortic intervention to identify distal aortic
disease not seen preoperatively by echocardiography, to as-
sess the distal anastomosis within 3 months of surgery, and
to establish a new baseline for future comparison.
With respect to mitral valve dysfunction in patients with
MFS, repair of the valve was achieved in the majority of
patients regardless of the mechanism of dysfunction. The
long-term results of mitral valve repair were excellent with
no patient requiring subsequent valve replacement. Our find-
ings substantiate previous reports that tout the feasibility and
durability of mitral valve repair in patients with MFS.9,22
Mitral valve repair rather than replacement is especially
preferred in children because anticoagulation can be avoided.
During our investigation on the impact of surgical inter-
ventions in children with aortopathies, we discovered that
postoperative angiotensin-converting enzyme inhibitor ther-
apy confers a long-term clinical benefit over beta-blocker
therapy in this cohort of patients. This is not surprising in
light of the accumulating data suggesting a beneficial role
of angiotensin II blockade in patients with MFS.23,24
The study is limited by its retrospective design with no
randomization of patients to the various surgical techniques.
In addition, the study includes a relatively small cohort of
patients with few adverse outcomes, which precluded
more extensive analyses. However, it is one of the larger
studies to date focusing on this group of patients, and as
such, it adds to the paucity of data on cardiovascular surgery
in children with MFS or LDS. Moreover, we differentiated
patients with MFS from those with LDS, a potential con-
founder in studies published before the description of LDS
in 2005.
TABLE 5. Multivariate analysis of significant independent variables
Variable OR P 95% CI
Preoperative AI 22 .05 (0.92–547)
Type of surgery
Mechanical valve/VSRR 1.1 .95 (0.04–19)
Postoperative ACEI 0.08 .04 (0.007–0.92)
OR, Odds ratio; CI, confidence interval; AI, aortic insufficiency; VSRR, valve-sparing
root replacement; ACEI, angiotensin-converting enzyme inhibitor.ardiovascular Surgery c Volume 137, Number 6 1331




This study brings to light the success of valve-sparing
aortic procedures in patients with aortopathies and high-
lights the need for further investigation to determine the
valve-sparing technique that will afford the best long-term
durability. This study also underscores the extent of aortic
pathology in patients with these syndromes, especially
LDS, and substantiates the importance of continued surveil-
lance for aortic aneurysm and dissection beyond the ascend-
ing graft, as well as the need for studies to assess the benefit
of medical therapies preoperatively and postoperatively in
these patients.
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Discussion
Dr Anees J. Razzouk (Loma Linda, Calif). Congratulations on
a nice presentation. Ivan Rebeyka regrets not being here this morn-
ing. I will be reading his comments and asking you his questions.
The authors are to be applauded for their initiative in combining
the experience from separate centers in Salt Lake City and Denver
to provide us with important information in the management of
children with Marfan and Marfan-like syndromes. The essence of
their data relates to the 30 patients who underwent aortic root sur-
gery at a mean age of 14 years and in whom 21 had a valve-sparing
procedure compared to 9 having a composite replacement or a Ben-
tall-type procedure. The two most important surgical decisions re-
quired in this group of patients is when to operate and if so what
operation to perform. While it is difficult to argue with reasonably
well established and accepted indications for surgery based on an
aortic size greater than 45 to 50 mm, the decision to operate be-
comes more challenging when younger and smaller patients present
with large ascending aortas relative to their body size but less than
45 mm in diameter. For example, a 2-year-old weighing 15 kg
might present with a 30-mm ascending aorta yet only to have
a valve annulus size of 16 mm. How do you decide if and when
such a patient should be advised to have an operation?
Dr Everitt. I think one of the most important things is to be sure
you have the diagnosis correct. In our paper, we did show that there
is a difference between patients with Marfan syndrome versus
Loeys-Dietz with respect to complications. Those patients, as pre-
viously published, were more likely to have dissection and death
due to dissection. The published criteria which is what we follow
for Loeys-Dietz is Z-score, so if the Z-score is greater than or equal
to 3.5, we will operate at an aortic root size less than 45 mm, so
based on index to body surface area. There were patients who
were identified after 2005 who had an aortic root in the 30s that
did undergo the procedure. As far as those with Marfan syndrome,
we are still following the criteria of 50mm unless they have a family
history of dissection or the rapid growth. I agree that it is a chal-
lenge. I think the literature prior to 2005, much of the literature after
2005, and our experiences have heterogeneous patient population
and, like I said, it is important to know what type of aortic pathol-
ogy you are dealing with, not only to determine the size at which to
operate but also the extent of the operation because these patients
with Loeys-Dietz syndrome have aortic pathology beyond what
we standardly replace in Marfan syndrome. We follow the recom-
mendations to image the entire aorta preoperatively with MRI scan
as our method of choice and to follow them yearly withMRI scan to
look for further dissection. That was the cause of death. There were
four deaths in our paper and three deaths were due to dissection. All
three patients had Loeys-Dietz syndrome.
Dr Razzouk. My last question relates to your conclusion sup-
porting the success of valve-sparing techniques over compositergery c June 2009
Everitt et al Congenital Heart Disease
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Daortic root replacement with mechanical valve in this patient pop-
ulation. More specifically, 4 out of 8 or 50% of patients undergoing
the remodeling technique had an adverse outcome defined by you
as need for reoperation, new aortic dissection, or death. Conversely,
only 1 of 12 or less than 10% of patients having the reimplantation
or David procedure experienced one of these issues. Accordingly, I
was wondering why you did not include the apparent superiority of
reimplantation procedure over remodeling as one of the study’s im-
portant messages.The Journal of Thoracic and CAgain, congratulations on your superb results and your very nice
presentation.
Dr Everitt. I did not want to make that statement too strongly
because our numbers were small and we did show a difference in
univariate analysis but not in multivariate analysis, so there may
be other confounding factors. I do think that it is very suggestive
that the reimplantation technique is superior but I think making de-
finitive conclusions are difficult with a small patient population, al-
beit one of the largest series to be published in children.ardiovascular Surgery c Volume 137, Number 6 1333
